Babatunde Olaiya

Babatunde Olaiya practices at UPMC Carlisle in Carlisle, Pennsylvania, part of University of Pittsburgh Medical Center.

Babatunde Olaiya's NPI, 1659895282, was assigned on July 25, 2017. Babatunde Olaiya holds Iowa license 47057.

Babatunde Olaiya's primary practice is UPMC Carlisle, at 361 Alexander Spring Road, Carlisle, PA 17015 in Cumberland County. The practice phone is (717) 249-1212.

Babatunde Olaiya's primary practice is UPMC Carlisle in Carlisle, Pennsylvania, part of University of Pittsburgh Medical Center. Babatunde Olaiya is also affiliated with UPMC Harrisburg. The medical group on file is WellSpan Digestive Health. Dmand AI also links Babatunde Olaiya to 3 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Babatunde Olaiya practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Babatunde Olaiya's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Babatunde Olaiya is licensed in Iowa.

CMS data shows 557 Medicare services from Babatunde Olaiya across 14 procedure codes in 2024, for 175 Medicare patients. Medicare paid $32,756 for them.

CMS counts 175 Medicare patients who saw Babatunde Olaiya in 2024. The largest group is 65 to 74, with 93 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Babatunde Olaiya's median patient age at 71, with 47% women.

In 2024, Babatunde Olaiya wrote 199 Medicare Part D claims for 96 patients. 78% of them were for generic drugs. CMS names the drug for 148 of them, across 5 drugs with 11 or more claims each, at $21,036 in total drug cost. In 2021, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Babatunde Olaiya for performance year 2024, reported as part of a group. Babatunde Olaiya accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 82 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Babatunde Olaiya, more than 72% of the clinicians it reports for that procedure.

Dmand AI links 7 papers to Babatunde Olaiya, published from 2019 to 2020. 2020 was the busiest year, with 4. The most frequent topics are Inpatients and Intestinal Perforation. Babatunde Olaiya's most frequent co-authors are Douglas Graham Adler, MD, Qiang Cai, MD and Saurabh Chandan, MD.

CMS Open Payments shows 4 general payments to Babatunde Olaiya from 3 drug and device companies from 2023 to 2024. Food and beverage make up the largest share, 100% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $141.